MOBIUS THERAPEUTICS, LLC
ST. LOUIS, MO

Mobius Therapeutics, LLC is a distinguished entity in the field of ophthalmic pharmaceuticals. With over a century of combined experience among its management team, Mobius exemplifies exceptional leadership in advancing ophthalmologic surgery and perioperative care. The company's unwavering commitment to assisting ophthalmologists and their patients aligns with its mission to drive innovation that enhances patient care while improving access and safety for medical providers. Born in Florida on January 5, 2011, with a filing number of M11000000069, Mobius Therapeutics is classified as a Foreign Limited Liability Company (FORL). Although its mailing address is situated at 1000 Executive Parkway, St. Louis, MO, the company's operations are rooted across various states due to its vast network. Key leadership includes Edward J Timm, serving as Chief Executive Officer, and Mark W Wright fulfilling the role of CFO. The vision extends beyond pharmaceuticals; Mobius Therapeutics aspires to lead in ophthalmic perioperative therapies by addressing challenging medical needs through innovative solutions. This commitment is supported by a robust sales team, each member possessing over 20 years of clinical experience specialising in ophthalmic surgery. Mobius maintains a proactive approach toward customer service and educating health professionals, consistently emphasizing vision care affordability and quality. For further information about their operations, services, or strategic insights into perioperative advancements, stakeholders may refer to their website at mobiustherapeutics.com.